2023 Assisted Circulation Gordon Research Conference and Seminar
2023年辅助循环戈登研究会议暨研讨会
基本信息
- 批准号:10682886
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-17 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAcademic supportAccelerationAddressAdverse eventAreaAssisted CirculationBasic ScienceBudgetsCardiacCaringClinicalCollaborationsCommunitiesConsensusDataDevelopmentDevice DesignsDevicesDisciplineEngineeringEthnic OriginFundingFutureGenderGeographyGoalsGovernmentHealth PersonnelHealthcareHeart TransplantationHeart failureHemorrhageHospitalsHuman BiologyIndustryInfectionInstitutionInternationalLifeMedicalMedicineMentorsMethodologyMethodsMonitorNew HampshireOrgan DonorParticipantPatient-Focused OutcomesPatientsPharmaceutical PreparationsPreparationPrevalenceProblem SolvingPrognosisQuality of lifeRecoveryRefractoryResearchResearch PersonnelResourcesRewardsScienceScientistSummary ReportsSurveysTechnologyThinkingThrombusTranslatingTranslational ResearchTransplantationTravelUnderrepresented MinorityWomanadjudicationblood damagecareerclinical investigationclinical practiceclinical translationclinically significantcostdata sharingdesignevidence baseexperiencefollow-upimprovedimproved outcomeinnovationintervention costmechanical circulatory supportmeetingsminority childrenminority scientistmultidisciplinarynovelpatient populationpharmacologicpostoperative recoveryprogramsprospectiveresearch and developmentsuccesssymposiumtooltranslational approach
项目摘要
Project Summary – The Gordon Research Conference (GRC) on Assisted Circulation is a bi-annual meeting
consisting of a diverse group of invited speakers, discussion leaders, and participants who are internationally-
recognized clinicians, engineers, and scientists pioneering the field of mechanical circulatory support (MCS)
and related disciplines. Our GRC program committee has developed a one-week program in preparation for
our next GRC on Assisted Circulation to be held in in Waterville Valley, New Hampshire from May 28 - June 2,
2023. The focus of our comprehensive GRC program is on the latest emerging developments in the MCS
field, including the presentation of previously unpublished data, clinical and scientific evidence-based research
and development activities, and introducing novel concepts that impact the future of MCS therapy and are
designed to improve heart failure (HF) patient outcomes and restore their quality of life. Invited speakers are
pioneers in the MCS field and related disciplines that will present their ground-breaking research and
development in critical areas of need. Discussion leaders will promote and actively engage audience
participation to encourage open and interactive exchange of concepts and ideas that are provocative and
stimulating to facilitate and rapidly accelerate advancement of MCS therapy. GRC participants will be
comprised of multi-disciplinary (clinical, engineering, science), multi-institutional (academic, industry, hospital,
government), and multi-diversity (career-stage, ethnic, gender, geographical) participants adjudicated by GRC
and Program Committee to be inclusive and representative of wide-range of experience, expertise, ideas, and
unbiased prospective. Our GRC program committee is requesting supplemental funding ($10,000 budget),
specifically to support travel-related expenses for ten early-stage invited speakers of diverse background
(women and/or non-white) in the MCS field or related discipline. The primary goal of the GRC on Assisted
Circulation will be to address and achieve each of the following objectives: (1) identify best clinical practices
and provide inventive methods to achieve consensus and harmonize best practices among MCS centers and
health care providers; (2) review the latest advancements in novel MCS device technologies that represent
disruptive or revolutionary ideas in the field as well as highlight a "conceptual thinking" session, where GRC
participants can contribute to the development of novel device designs or innovative ways of problem solving;
and (3) highlight novel basic science discoveries and innovative methods to translate these discoveries into
best practices, including human biology and the changes and adaptation of the human biology associated with
the presence of MCS device therapy. GRC surveys will be completed by all attendees (invited speakers,
discussion leaders, participants) to assess program quality and whether objectives were successfully met, and
the program committee will complete a summary report highlighting critical areas of need and establishing Best
Practices criteria.
项目摘要 - 辅助循环的戈登研究会议(GRC)是一年一次的会议
由一个受邀演讲者,讨论领导者和国际参与者组成的潜水员组成
公认的临床医生,工程师和科学家开创了机械电路支持领域(MCS)
和相关学科。我们的GRC计划委员会已制定了一个为期一周的计划,以准备
我们的下一个GRC从5月28日至6月2日在新罕布什尔州沃特维尔谷举行的辅助循环
2023年。我们综合GRC计划的重点是MCS的最新新兴发展
领域,包括呈现先前未发表的数据,临床和科学证据研究
和开发活动,并引入影响MCS治疗未来的新颖概念,并且是
旨在改善心力衰竭(HF)患者的结果并恢复其生活质量。受邀演讲者是
MCS领域和相关学科的开拓者将展示其开创性研究和
在关键需求领域的发展。讨论领导者将促进并积极吸引观众
参与鼓励开放和互动的概念和思想,这些概念和思想具有挑衅性和
刺激以促进和快速加速MC疗法的进步。 GRC参与者将
完成多学科(临床,工程,科学),多机构(学术,工业,医院,
政府)和多样性(职业阶段,种族,性别,地理)参与者由GRC裁定
计划委员会包容性,代表广泛的经验,专业知识,思想和
无偏见的前瞻性。我们的GRC计划委员会要求补充资金(预算10,000美元),
专门用于支持十个早期邀请的潜水者背景的与旅行有关的支出
(妇女和/或非白人)在MCS领域或相关学科中。 GRC辅助的主要目标
循环将解决并实现以下每个目标:(1)确定最佳临床实践
并提供创造性的方法来达成共识并协调MCS中心的最佳实践和
医疗保健提供者; (2)回顾代表的新型MCS设备技术的最新进步
该领域中的破坏性或革命性思想,并突出显示“概念思维”会议,其中GRC
参与者可以为新的设备设计或创新解决问题的方法做出贡献;
(3)重点介绍了新颖的基础科学发现和创新方法,以将这些发现转化为
最佳实践,包括人类生物学以及与人类生物学的变化和适应
MCS设备治疗的存在。 GRC调查将由所有与会者完成(被邀请的演讲者,
讨论领导者,参与者)评估计划质量以及是否成功实现目标,以及
计划委员会将完成一份摘要报告,该报告突出了关键的需求领域并建立最佳
实践标准。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kurt A Dasse其他文献
Kurt A Dasse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kurt A Dasse', 18)}}的其他基金
Development of the Inspired Therapeutics NeoMate Mechanical Circulatory Support System for Neonates and Infants
新生儿和婴儿 Inspired Therapeutics NeoMate 机械循环支持系统的开发
- 批准号:
10547304 - 财政年份:2018
- 资助金额:
$ 1万 - 项目类别:
相似国自然基金
人机协同反馈对学生在线学习行为的影响研究
- 批准号:72304057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ASM支持的污水处理系统智能优化调控模型及其在线进化学习机制
- 批准号:52300031
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Optimizing the implementation of personalized risk-prediction models for venous thromboembolism among hospitalized adults
优化住院成人静脉血栓栓塞个性化风险预测模型的实施
- 批准号:
10658198 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Center for Virtual Care Value and Equity (ViVE)
虚拟护理价值和公平中心 (ViVE)
- 批准号:
10621602 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
AnVIL Clinical Environment for Innovation and Translation (ACE-IT)
AnVIL 创新与转化临床环境 (ACE-IT)
- 批准号:
10747551 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
An innovative telomerase-targeted, circulating tumor cell assay for monitoring NSCLC treated with radiation and immunotherapy
一种创新的端粒酶靶向循环肿瘤细胞检测方法,用于监测接受放射和免疫疗法治疗的非小细胞肺癌
- 批准号:
10546634 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
NHLBI INNOVATION AND COMMERCIALIZATION ECOSYSTEM DATA SUPPORT, EVALUATION, AND ANALYSIS
NHLBI 创新和商业化生态系统数据支持、评估和分析
- 批准号:
10929284 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别: